Document is current

Any future updates will be listed below

1365 An active site PTPN2/N1 small molecule inhibitor promotes anti-tumor efficacy by sensitizing tumor cells to inflammatory signals and enhancing immune cell activity

Crossref DOI link: https://doi.org/10.1136/jitc-2022-SITC2022.1365

Published Online: 2022-11-07

Published Print: 2022-11

Update policy: https://doi.org/10.1136/crossmarkpolicy

About CrossMark